Finding N=51
Death during follow-up, n (%) 4 (7.8)
Cardiac-related death, n (%) 0 (0.0)
Lost to follow-up, n (%) 2 (3.9)
Rehospitalization for cardiac event, n (%) 7 (13.7)
Rehospitalization for non-cardiac event, n (%) 11 (21.6)
Aortic valve-related reintervention, n (%) 3 (5.9)
By indication
Aortic valve insufficiency, n (%)
0 (0.0)
Aortic valve stenosis, n (%)
1 (2.0)
Endocarditis, n (%)
2 (3.9)
By type of reintervention
Mechanical aortic valve replacement, n (%)
1 (2.0)
Biological aortic valve replacement, n (%)
0 (0.0)
Bentall procedure with biological prosthesis, n (%)
0 (0.0)
Bentall procedure with mechanical prosthesis, n (%)
2 (3.9)
Ross procedure, n (%)
0 (0.0)
Transcatheter aortic valve implantation, n (%)
0 (0.0)
Mortality at reintervention, n (%)
0 (0.0)
Concerning the medical treatment 45 (88.2)
Cardiologic medication, n (%)
34 (66.7)
Anticoagulant, n (%)
3 (5.8)
Others, n (%)
2 (3.9)
None, n (%)
6 (11.8)
Echocardiography with last 2 years 37 (72.5)
Left ventricular ejection fraction (%) (n=36), mean±SD
62.6±6.7
Aortic ring (mm) (n=7), mean±SD
22.7±4.1
Vmax (m/s) (n=17), mean±SD
2.0±0.6
Aortic insufficiency, n (%)
0
31/37 (83.8)
1
5/37 (13.5)
2
1/37 (2.7)
3
0/37 (0.0)
4
0/37 (0.0)
Mean gradient (mmHg) (n=27), mean±SD 9.4±5.4
Ascending aorta (mm) (n=22), mean±SD 34.7±5.4